High Demand for Vitamins and Mineral Dietary Supplements and Health Functional Foods act as Major Driver for Nutraceuticals Market in Asia Pacific: Ken Research


Health segment dominated the functional food and beverages market segment in Asia Pacific.

Herbal supplements are expected to drive the dietary supplements market in Asia Pacific

China dominated the overall Asia Pacific Nutraceuticals market in 2016

Changing lifestyle and increasing preference towards healthy style of eating act as major driver for the Asia Pacific Nutraceuticals Market

Ken Research in its latest study, Asia Pacific Nutraceutical Market Outlook to 2021 suggested that vitamins and minerals will maintain their dominance in the dietary supplements market during the forecast period. High prevalence of vitamin deficiency among people residing in the region coupled with growing geriatric population is expected to result in orthopedic disorders, necessitating the requirement of dietary supplements for completing nutritional needs.

The report provided information on market size for Asia Pacific nutraceuticals market, Asia Pacific nutraceuticals market segmentations on the basis of dietary supplements, functional food & beverages and by countries. Detailed analysis on seven major geographies in Asia Pacific region including India, China, Japan, Korea, Thailand, Australia, and Vietnam has been explained in detail for providing clear understanding about the current and future dynamics of nutraceuticals market of Asia Pacific to stakeholders.

Vitamins and minerals demand in Asia Pacific is driven by rising health consciousness among the ageing population, and high incidence rate of vitamin deficiency in the region. Consumption of vitamins in the human healthcare and personal care markets is driven by urbanization, and the resulting rise in stress caused by hectic lifestyles and pollution. B-complex vitamins, vitamin E and multivitamin are few of the most widely consumed vitamins which are driving the market for the segment in Asia Pacific region. Herbal supplements were observed to record highest growth in the market, supported by the fact that many herbal companies are strongly promoting their products for beauty enhancement and health improvement. Korea Ginseng is major example of the same. However, rising prevalence of digestive disorders owing to increased consumption of junk food has also resulted in high demand for probiotics in the region.

Health segment has been observed as the most popular type of functional foods and beverages in Asia-Pacific region. Rising health consciousness among the Asia-Pacific countries is urging the manufacturers of functional foods to meet the transforming demand of growing nutrition. Manufacturers are introducing functional fortified foods for specific target audience which is helping them in generating extra revenue from the segment. Huge presence of undernourished population in the region is also assisting the segment in gaining high demand in the market.

For further reading click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/asia-pacific-nutraceuticals-market-report/118296-91.html

Related Reports by Ken Research

https://www.kenresearch.com/healthcare/pharmaceuticals/global-nutraceuticals-market-research-report/514-91.html

https://www.kenresearch.com/healthcare/general-healthcare/qatar-wellness-services-products-market/54090-91.html

https://www.kenresearch.com/healthcare/general-healthcare/india-alternative-medicine-herbal-products-report/592-91.html

Contact:         

Ken Research

Ankur Gupta, Head Marketing & Communications

query@kenresearch.com

+91-124-4230204

https://www.kenresearch.com/blog/2017/06/high-demand-vitamins-mineral-dietary-supplements-health-functional-foods-act-major-driver-nutraceuticals-market-asia-pacific-ken-research/

Rising Demand for Infant Products Coupled with Launch of Novel Products in this Category to Drive Nutraceuticals Market in Asia Pacific: Ken Research


Extensive customers’ base coupled with rising disposable income in India and China to Drive Nutraceuticals Market in Asia Pacific region.

The report titled “Asia Pacific Nutraceutical Market Outlook to 2021 – Extensive Customer Base Coupled with Rising Disposable Income in India and China to Foster Growth” by Ken Research suggested that nutraceuticals market in Asia Pacific would showcase high growth during the forecast period. Rising health consciousness among the Asia-Pacific countries is urging the manufacturers of functional foods to meet the transforming demand of growing nutrition. Manufacturers are introducing functional fortified foods for specific target audience which is helping them in generating extra revenue from the segment.

Growing and increasing consumer demand for natural/herbal products that promote healthy living lifestyle and for treating diseases in China is one of the major factors which have driven the market for Asia Pacific nutraceuticals market.  Additionally, the large presence of customer base in the country coupled with rising disposable income to purchase expensive nutraceuticals further impacted the overall Asia Pacific market in a positive manner. Similarly, Indian market is observed to grow at a high pace, with country recording growth at a highest CAGR in the entire region. Rising disposable income, increasing awareness, investments by international players, launch of new products, aging population and high prevalence of diabetics and obese people in the country is observed to benefit the market revenue of India in a positive manner. The willingness to adopt a healthy living lifestyle and spending towards high quality nutritional supplements in India further helped the overall market in its growth during the historical period.

The revenues of Asia Pacific nutraceuticals market are observed to continuously increase at a high pace during the historical period. The changing lifestyles and increasing preferences towards healthy style of eating are acting as major driving forces for Asia Pacific nutraceuticals market. The changing lifestyle which includes excessive consumption of junk food, smoking and alcohol has resulted in imbalance in nutritional requirements, leading to high demand for nutraceuticals in the region. In addition to that, people in Asia Pacific region have diverted their attention towards preventive healthcare rather than curative healthcare, which requires regular consumption of dietary supplements and functional foods to improve immune system against diseases.

Key Topics Covered in the Report:

Vitamin and Supplement Industry Analysis

Nutraceutical Sales Asia

Nutraceutical Market Growth, Trends & Forecasts‎

Fitness Nutrition Market Asia

Probiotic Market Share Asia

Dietary Supplements Market Size

Vitamin Supplements Market Analysis

Vitamin Supplements Market Asia

Global Dietary Supplements Market Size

Wellness Supplements Market Asia

Nutritional Supplement Industry Statistics

Asia-Pacific Nutraceuticals Market by Type

For further reading click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/asia-pacific-nutraceuticals-market-report/118296-91.html

Related Reports by Ken Research

https://www.kenresearch.com/healthcare/pharmaceuticals/global-nutraceuticals-market-research-report/514-91.html

https://www.kenresearch.com/healthcare/general-healthcare/qatar-wellness-services-products-market/54090-91.html

https://www.kenresearch.com/healthcare/general-healthcare/india-alternative-medicine-herbal-products-report/592-91.html

Contact:

Ken Research

Ankur Gupta, Head Marketing & Communications

query@kenresearch.com

+91-124-4230204

https://www.kenresearch.com/blog/2017/06/rising-demand-infant-products-coupled-launch-novel-products-category-drive-nutraceuticals-market-asia-pacific-ken-research/

Asia Pacific Nutraceuticals Market Outlook to 2021: Ken Research


The report titled “Asia Pacific Nutraceuticals Market Outlook 2021 – Extensive Customer Base Coupled with Rising Disposable Income in India and China to Foster Growth” provides a comprehensive analysis of nutraceuticals market in Asia-Pacific region. The report focuses on overall market size for Asia Pacific nutraceuticals market, market segmentation on the basis of Dietary Supplements, Functional Foods and Beverages, sub-segmentations on the basis of Dietary Supplements by Type of Supplements, Functional Foods and Beverages by Food Category and market segmentation by countries (China, Japan, India, Australia, Korea, Thailand, Vietnam). The report also covers competitive landscape and market share of major players in nutraceuticals market, countries’ import and export scenario, major government regulations and future projections for nutraceuticals market in each country. The report concludes with market projection for future and analyst recommendation highlighting the major opportunities and cautions.

Asia Pacific Nutraceuticals Market

Asia Pacific nutraceuticals market has been recorded as USD ~ million in 2011 and USD ~ million in year 2016, exhibiting growth at a CAGR of ~ % during the period. The changing lifestyles and increasing preferences towards healthy style of eating are acting as major driving forces for Asia Pacific nutraceuticals market. The changing lifestyle which includes excessive consumption of junk food, smoking and alcohol has resulted in imbalance in nutritional requirements, leading to high demand for nutraceuticals in the region. In addition to that, people in Asia Pacific region have diverted their attention towards preventive healthcare rather than curative healthcare, which requires regular consumption of dietary supplements and functional foods to improve immune system against diseases.

Asia Pacific Nutraceuticals Market Segmentation

Asia Pacific Nutraceuticals market is segmented on the basis of three major segments- by dietary supplements, by functional foods and beverages market and by countries. The dietary supplements segmentation is sub-segmented on the basis of types of supplements. Functional Foods and beverages market is further sub-segmented on the basis of food category.

By Dietary Supplements, and Functional Foods and Beverages

Functional foods and beverages segment dominated the Asia Pacific nutraceuticals market with revenue share worth ~% by the year ending 2016. Increasing consumer awareness about health and fitness in the Asia Pacific region is a major driving force which has boosted the demand for functional foods and beverages market. Additionally, elevating consumption of processed food in developing economies such as India and China and rising GDP, which allows users to purchase expensive functional foods and beverages, is further assisting the segment to generate high revenue. On the other hand, dietary supplements have been observed to capture remaining share of the market with growth recorded at a CAGR of ~% in between 2011 and 2016. Increased consumption of junk food, smoking and alcohol has resulted in deficiency of various nutrients in the bodies of Asian people, which has resulting in various lifestyle diseases which majorly includes cardiac disorder, obesity, and diabetes. As a preventive measure of these diseases and for management purpose, doctors in the region are highly prescribing nutraceuticals for completing nutritional requirement of the body and for improvisation of immune system, hence driving the market.

Dietary Supplements Segmentation by Type of Supplements

Vitamins and minerals dominated the market with revenue share of ~% in 2016, driven by rising health consciousness among the ageing population and high incidence rate of vitamin deficiency in the region. The herbal supplements market followed vitamins and minerals with revenue share of ~% in 2016 and is witnessed to showcase a high growth, supported by the fact that many herbal companies are strongly promoting their products for beauty enhancement and health improvement. Korea Ginseng is major example of the same. However, rising prevalence of digestive disorders owing to increased consumption of junk food has resulted in high demand for probiotics in the region, with segment recording growth at a CAGR of ~% in between 2011 and 2016.

Functional Foods and Beverages Market Segmentation by Food Category

Health segment dominated the functional food and beverages market with a revenue share worth ~% in Asia-Pacific functional foods and beverages market in year 2016. Rising health consciousness among the Asia-Pacific countries is urging the manufacturers of functional foods to meet the transforming demand of growing nutrition. Manufacturers are introducing functional fortified foods for specific target audience which is helping them in generating extra revenue from the segment. The example of this can be omega 3 fortified foods for heart health problems. The digestive segment followed health functional foods and beverages market by capturing revenue share worth ~% of Asia Pacific region in 2016. It has been witnessed that the segment is continuously growing at a CAGR of ~% for the projected period of six years from 2011 to 2016 majorly due to rising prevalence of digestive disorders in the region.

By Countries

China dominated the Asia Pacific nutraceuticals industry by grabbing revenue share worth ~% of the overall market by the year ending 2016 majorly due to growing and increasing consumer demand for natural/herbal products that promote healthy living lifestyle and for treating diseases. Additionally, the large presence of customer base in the country coupled with rising disposable income to purchase expensive nutraceuticals is further driving the market in the country. Japan followed China in the Asia Pacific nutraceuticals market by capturing revenue share worth ~% of the overall market in 2016 which is backed by growing demand for joint health and weight loss supplements such as konnyaku, non-caloric fiber for weight loss in the country. Other major countries in the region, India and Australia captured revenue share of worth ~% and ~% in the total market in year 2016 respectively.

Asia Pacific Nutraceuticals Market Future Outlook & Projections

Asia Pacific nutraceuticals market is expected to showcase growth at a CAGR of ~% during the forecast period of four years from 2016 to 2019 owning to the rising demand of dietary supplements in various countries such as China, Japan and Korea and increasing lifestyle shift of consumers towards preventive therapies. Rising disposable income coupled with growing knowledge and awareness about health and fitness are also witnessed as some of the major driving forces for expanding nutraceuticals demand in Asia Pacific countries. Rising population in various countries including India and China, which has provided huge customer base in the region to the market players operating in the market is expected to further assist the companies generate high revenue during the forecast period. The dietary supplements market in Asia Pacific region is expected to grow at a CAGR of ~% for the projected period of six years from 2016 to 2021 majorly due to high sale of vitamins and minerals, containing micronutrients which are intended to aid human body function smoothly and enhance mental health.

Key Topics Covered in the Report:

Introduction to Asia Pacific Nutraceuticals Market, 2011-2016

Nutritional Supplement Industry Trends

Asia Pacific Dietary Supplements Market

Asia Pacific Nutraceuticals Market Size, 2011-2016

Asia Pacific Nutraceuticals Market Segmentation by dietary supplements, food & beverages and countries

Vitamin and Supplement Industry Analysis

Asia Pfizer Revenue Nutritional Supplements

Dietary Supplements segmentation by type of supplements

Foods and Beverages Market Segmentation by Product Category

Vitamin and Supplements Market

Dietary Supplements Industry Growth

China Nutraceuticals Market

Prebiotics Market Asia

Japan Nutraceuticals Market

Sports Nutrition Market Asia

Health Supplements Market Asia

India Nutraceuticals Market

Australia Nutraceuticals Market

Growth Global Dietary Supplements Market Asia

Nutraceuticals Market Asia Pacific Industry Analysis

Korea Nutraceuticals Market

Thailand Nutraceuticals Market

Asia Nutraceutical Market

Supplement Sales Statistics

Vietnam Nutraceuticals Market

Major Trends and developments

Analyst Recommendations

Competitive Landscape of Major Players in Asia Pacific Nutraceuticals Market

Asia Pacific Future Outlook and Projections, 2017-2021

For further reading click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/asia-pacific-nutraceuticals-market-report/118296-91.html

Related Reports by Ken Research

https://www.kenresearch.com/healthcare/pharmaceuticals/global-nutraceuticals-market-research-report/514-91.html

https://www.kenresearch.com/healthcare/general-healthcare/qatar-wellness-services-products-market/54090-91.html

https://www.kenresearch.com/healthcare/general-healthcare/india-alternative-medicine-herbal-products-report/592-91.html

Contact:         

Ken Research

Ankur Gupta, Head Marketing & Communications

query@kenresearch.com

+91-124-4230204

https://www.kenresearch.com/blog/2017/06/asia-pacific-nutraceuticals-market-outlook-2021-ken-research/

Uprising European Influenza Vaccine Market- Ken Research


Europe is at the heart of global vaccine research and production. Influenza is a vaccine preventable disease and influenza vaccine has been available for use in Europe since 1960’s.

Approximately, at US$ 1 billion, Europe influenza market was closed. Nevertheless, the highest influenza market share was held by United Kingdom. West Europe has more than US$ 500 Million. United Kingdom, Germany, France, Italy and Spain hold 80 percent of influenza market share. France holds the second post, as United States holds the first post in children vaccine market. In addition, in adult vaccine market, United States and Germany was almost at a same pace.

 

Seasonal influenza vaccines need a yearly update because of constant evolution of influenza viruses in Europe and other countries as well. The match between selected vaccine virus and those found circulating determine the effectiveness of seasonal influenza vaccine, which vary from year to year. There is a meeting held each year in February, in order to find best match and increase the vaccine efficiency and effectiveness.

 

According to the market research report “Europe Influenza Vaccine Market & Forecast (23 Countries Market & Vaccinated Population Data) By (Pediatrics & Adult) & Vaccine Brands Analysis“, the immunity that is extended by influenza vaccines is not as long lived as the immunity following natural influenza infection. This is particularly so for those who belong to the risk group, hence people have to be vaccinated yearly. There are three influenza immunization strategies which is feasible but Europe is the country where it is firstly most important and widely used.

 

Discreet analysis has been made on the part of competitors.  There are three major players which have a major share of the influenza vaccine market in terms of revenue.The key influencers with their products in the influenza vaccine market are Sanofi Pasteur, GlaxoSmithKline (GSK), Seqirus, AstraZeneca and Protein Sciences Corporation. There are other emerging players as well as if Novavax, Daiichi-Sankyo, Mitsubishi Tanabe Pharma, BiondVax Pharmaceuticals Ltd and VaxInnate are making novel technology based influenza vaccine, which may tend to affect the market share in the future.

 

In Europe, protecting the vulnerable is one of the main strategies of immunization programs, which is to directly or indirectly protect individuals that are more vulnerable. Direct protection involves immunizing people who are more likely to develop austere disease if they are infected by influenza viruses. There is also an indirect protection strategy of immunizing those with close contact with people in risk groups. The importance of this is growingas that the ordinary influenza vaccines are more effective in healthy adults than older people and those with chronic conditions, including immunodeficiency and this is now accelerated. Moreover, children under six months of age that cannot be vaccinated and it may be protected by the indirect ammunition strategies.

 

To determine how effective influenza vaccines work each season, influenza vaccine efficaciousness is measured in observational studies. Vaccine productiveness is an estimate of the likelihood that a vaccine prevents influenza infection when used in everyday practice. In Europe influenza, vaccine effectiveness studies have been followed according in a desired manner since in year 2008-09, a network of public health and academic researchers. However, results have been come out by age group and by various influenza vaccine strains. In general, a vaccine effectiveness and cooperative assessment has been estimated for the three different influenza A (H1N1, H3N2) and B strains (Victoria or Yamagata lineages) apart from the last two seasons where only a limited effectiveness was observed against influenza yield by circulating H3N2 viruses due to mismatch.

 

Topics Covered in The Report

 

  • Europe Influenza VaccineMarket Research Report
  • Europe Influenza VaccineMarket Size
  • Europe Influenza VaccineMarket
  • Europe Influenza VaccineTrade Market
  • Europe Influenza VaccineProduction Output
  • Europe Influenza VaccineImport Volume
  • Europe Influenza VaccineExport Volume
  • Europe Influenza VaccineMarket Future Outlook
  • Europe Influenza VaccineMarket competition
  • UK Influenza VaccineMarket Research
  • Germany Influenza VaccineMarket Research
  • Spain Influenza VaccineMarket Research
  • Europe Seasonal Influenza Child Vaccine Market
  • Netherlands Seasonal Influenza Vaccine Market
  • Denmark Seasonal Influenza Vaccine Market
  • Finland Seasonal Influenza Vaccine Market
  • Ireland Seasonal Influenza Vaccine Market
  • Italy Seasonal Influenza Vaccine Market
  • Luxembourg Seasonal Influenza Vaccine Market
  • Romania Seasonal Influenza Vaccine Market
  • Germany Influenza Vaccine Market Growth
  • Germany Influenza Vaccine Market future
  • Germany Influenza Vaccine Market size
  • Germany Influenza Vaccine Market share

For further reading click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/europe-influenza-vaccine-market-forecast/104290-91.html

 

Related reports:

Global Bone Allograft and Xenograft Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Global Enteric Empty Capsules Market by Manufacturers, Countries, Type and Application, Forecast to 2022

 

Contact Us:

Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

www.kenresearch.com

https://www.kenresearch.com/blog/2017/06/uprising-european-influenza-vaccine-market-ken-research/

Asia, a Prominent Market for Proton Therapy–Ken Research


Proton therapy is used to treat cancer and tumours through a beam of protons to irradiate the diseased tissue. It is a type of radiation therapy that uses a particle accelerator to charge protons to treat diseases specially cancer. It is one of the most advanced type of particle therapy available throughout. Proton therapy can be used to treat tumours that are near imperative parts of the body. For example, tumours near the eye, brain, and spinal cord. In proton therapy, there are less chances of harming the healthy, developing tissue so it is used to treat childhood cancers of brain, eye and spinal cord. This therapy may also be used other cancers including lung cancer, liver cancer, spinal and pelvic sarcomas, eye cancer, head and neck cancer, prostate cancer and central nervous system cancers including chordoma, chondrosarcoma, and malignant meningioma.

At present Asia has about 15 proton therapy centres and it is expected that this number will increase to almost double in the coming years. This is because many facilities for proton therapy are either in under-construction or in the planning phase. Japan dominates the Asian proton therapy market and has the second largest market share globally. South Korea is the second largest provider of proton therapy in Asia. China and Korea have been increasing their contribution to the industry every year.

IBA, Varian Medical Systems and Elekta are some of the biggest companies that are present in the proton therapy industry globally.The leading company in Japan for proton therapy is Mitsubishi. However, there are many other companies who have managed to make a mark on the Japanese market like IBA, Hitachi, and Sumitomo etc. China has the largest population in the world and consequently the number of cancer patients is gigantic. This provides a huge market opportunity that has been identified by companies well. IBA already has one operational proton therapy centre in China and four more centres are in development phase. Two proton therapy centres are under development in India and are scheduled to start in 2018 and 2019.

Around 60% of the total world population lives in Asia and it is home to nearly half of the cancer patients. This provides a lot of potential to grow and expand for the proton therapy industry. There is a huge gap between the demand and supply of proton therapy. The cases of cancer have been increasing rapidly and the demand for the therapy is high but the number of patients that can be treated is relatively low due to the limited availability of proton therapy centres. One of the major hindrance in the proton therapy industry is the cost and size of the particle accelerator, synchrotron. It requires high initial investment and is quite outsized too. Many companies have been trying to enlarge accelerators that are smaller. Some of the technologies that are being considered include ultra-compact synchrotrons, linear particle accelerators, super conducting synchrocyclotrons and dielectric wall accelerators.

Topics Covered in The Report

  • Asia Proton Therapy Market Research Report
  • Asia Proton Therapy Market Size
  • Asia Proton Therapy Market
  • Asia Proton Therapy Market Structure
  • Asia Proton Therapy Output
  • Asia Proton Therapy Market Future Outlook
  • Asia Proton Therapy Market competition
  • Proton therapy Global Market research Report
  • Asia Proton Therapy Market future
  • Asia Proton Therapy Market growth
  • Asia Proton Therapy Market trends
  • Asia Proton Therapy Market share
  • Asia Proton Therapy Market analysis
  • Asia Proton Therapy Market trend

For further reading click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/asia-proton-therapy-market-forecast/104292-91.html

Related reports:

Global Bone Allograft and Xenograft Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Global Enteric Empty Capsules Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Contact Us:

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91-9015378249

www.kenresearch.com

https://www.kenresearch.com/blog/2017/06/asia-prominent-market-proton-therapy-ken-research/

Progression of Advance Infusion Systems in the US: Ken Research


Advanced Infusion Systems are a category of devices used to administer liquid drugs into the patient’s circulatory system. One of the best ways to administer a drug into the patient’s system is through intravenous, although arterial, subcutaneous and epidural infusion is more favourable. Advanced Infusion Systems are widely used because of their dependable, ergonomic design and user-friendly characteristics. Originally, infusion systems are used for medication purpose but due to high death rates, advanced infusion systems are developed.

According to the research report “United States Advanced Infusion Systems Market Research Report Forecast 2017 to 2022“, in the United States there is an increase in aged population with diabetes, cancer and lifestyle diseases that has encouraged the development and growth in the advanced infusion systems market. Enormous developed technology in advanced infusion systems helps to eradicate user-related risks, safety, therapeutic effectiveness, higher bio availability, and increase in healthcare spending. These factors also boost in the growth of the advanced infusion systems market.

The advanced infusion systems globally is analysed under various regions namely North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America is the largest regional segment in the global advanced infusion systems market and accounts for a larger share compared to the other regions. This is mainly due to a great number of people suffering from prolonged diseases, high prevalence of cancers and lifestyle diseases.

The factors affecting the progress in the advanced infusion systems market in the USA are frequency of chronic diseases along with increasing aged population, consumers’ adoption of portable infusion systems to reduce hospital expenditure, and constant increase in surgical procedural numbers. In the USA, the advanced Infusion Pumps are majorly used for chemotherapy/oncology, gastroenterology, analgesia/pain management, diabetes, pediatrics/neonatology, hematology, and other applications. In the year 2015, there was a significant growth because the chemotherapy/oncology segment accounted for a larger share of the advanced infusion systems. The increasing occurrence of diabetes is coupled with the management of insulin at home thus, expecting a rapid growth of advance infusion systems market.

The global advanced infusion systems and product type are divided based on Disposable Infusion System, Elastomeric Infusion System, Ambulatory Infusion System, Volumetric Infusion System, Patient Controlled Analgesia Pump, Syringe Infusion System and Implantable Infusion System. Clinical Nutrition, Chemotherapy, Pain Management, Diabetes and Asthma Treatment are the nature of the application types of the global advanced infusion systems. Globally the end-users of the advanced infusion systems are Hospitals, Ambulatory Surgical Centres, and Diagnostic Centres.

The major players in the global advanced infusion pumps market are Becton, Dickinson and Company (U.S.), Baxter International, Inc. (U.S.), Pfizer Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius SE & CO. KGaA (Germany), Medtronic plc (Ireland), Smiths Group plc (U.K.), Terumo Corporation (Japan), Moog, Inc. (U.S.), F. Hoffmann-la Roche Ltd.(Switzerland), and Johnson & Johnson (U.S.). Hospira is a leading competitor in infusion technologies globally.

The possible reasons that may affect this market growth in the coming years may be due to lack of skilled persons and unavailability of required training for users/staff to handle the advanced infusion systems. In addition to the stringent rules for product approvals and possible medical or medication blunders correlated to the advanced infusion pumps may also hinder the future growth of the market. In the coming years, the advanced infusion systems market would witness a steady growth with consumers’ increasing disposable income and healthcare expenditure, increase of chronic diseases with changing lifestyles, awareness in healthcare facilities, and ease of access to latest products.

Key Topics Covered in the Report:

United States Advanced Infusion Systems Market Research Report

United States Advanced Infusion Systems Market Size

United States Advanced Infusion Systems Market

United States Advanced Infusion Systems Trade Market

United States Advanced Infusion Systems Production Output

United States Advanced Infusion Systems Import Technique

United States Advanced Infusion Systems Export Technique

United States Advanced Infusion Systems Market Future Outlook

United States Advanced Infusion Systems Market Competition

For further reading click on the link below:

https://www.kenresearch.com/healthcare/medical-devices/united-states-advanced-infusion-systems/110768-91.html

Related reports:

https://www.kenresearch.com/healthcare/medical-devices/interventional-neurology-medical-devices/111279-91.html

https://www.kenresearch.com/healthcare/medical-devices/embolization-coiling-devices-medical-devices/111280-91.html

Contact:

Ken Research

Ankur Gupta, Head Marketing & Communications

query@kenresearch.com

+91-124-4230204

https://www.kenresearch.com/blog/2017/06/progression-advance-infusion-systems-us-ken-research/

Technology & Healthcare: The New Thoroughgoing Duo: Ken Research


Healthcare refers to the maintenance and improvement of medical care provisions for the people.The value of healthcare providers sector is calculated by the total expenditure on healthcare in the economy.The healthcare industry is one of the biggest contributors to GDP in the country. In Philippines, the FDA Act of 2009 provides the regulations for sale of medical products in the country. Licence to Operate (LTO) and Product Registration are the two main documents that are required to register for the sale of medical products. The healthcare sector in the country is very much dependent on imports, which includes import of medical equipment, disposables and devices and diagnostics. The domestically produced goods are syringes, gloves, hospital beds, needles and hospital furniture.

According to the market research report “Healthcare Providers in Philippines“, in 2016, the healthcare sector in Philippines had a total revenue of $14.3bn. In between 2012 and 2016, the industry exhibited a compound annual growth rate (CAGR) of 9.6%.The market was dominated by medical goods segment in the year 2016 with a market share of 35.5% of the total value and had contributed a total revenue of $5.1bn. The second largest segment was the inpatient care, which held 29.7% of the total market share and had contributed $4.2bn of revenue to the industry in 2016. There has been an increase in demand for affordable, quality and accessible healthcare.

In Philippines, the government has been supporting the growth of the healthcare sector and increased its spending on the segment to achieve full universal coverage. The government has combined the public sector funding with private sector to provide healthcare to the people. This has increased efficiency and has been one of the major reasons for the recent expansion of the sector. Even though the public sector’s contribution to the sector has been increasing but the private sector is still the bigger healthcare provider. Healthway Medical, Metro Pacific Investments Corporation, St. Luke’s Medical Centre and The Medical City are the biggest providers of healthcare services in the country. Metro Pacific Investments Corporation is the largest healthcare provider in the country with 11 hospitals and around 3000 beds. The demand for healthcare products comes from factors like aging population and the rise in the number of diseases. The most commonly used medical products are nebulizers, anaesthesia machines, x-ray equipment, infusion systems, incubators, autoclave and sterilizing equipment etc.

The healthcare sector has been experienced a growth in opportunities and activities in the recent years. The improvements in technology and communication have immensely benefitted the healthcare sector. Telemedicine is gaining popularity in the country. It refers to the exchange of information and data on medicines using electronic medium to treat the patients. It is very cost effective and efficient way for treatment and helps in monitoring patients in remote areas. Drones are now used to deliver simple medicines to the remote and inaccessible areas. The eHealth Strategic Framework and Plan is functional in the country with the objective to use technology to improve the healthcare sector. The companies are introducing products like wrist-worn sensors, which will measure blood pressure; pulse rates etc. and show the information on a smart phone.

  

For further reading click on the link below:

https://www.kenresearch.com/healthcare/pharmaceuticals/healthcare-providers-philippines/110503-91.html

Related reports:

Global Medical Alert Systems Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Global Bone Allograft and Xenograft Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

 

 

https://www.kenresearch.com/blog/2017/06/technology-healthcare-new-thoroughgoing-duo-ken-research/

Philippines Hospitals Market Size on the Basis of Revenue in USD Million- Ken Research


High prevalence of diseases due to growing population is the major factor which is driving the hospitals market in the Philippines. Additionally, rise in per capita healthcare expenditure, infrastructural development in the hospital industry and growing medical tourism in the country are the major factors which are further fuelling the hospitals market in the country. Southern Philippines Medical Center, Philippine Orthopedic Center, Lung Center of the Philippines, Vicente Sotto Memorial Medical Center, Healthcare Expenditure in the Philippines, Medical Tourism Industry of the Philippines,

Philippines hospitals market was inclined to USD ~ million in 2016, which included both government and private hospitals, recording a CAGR of ~% in between 2014 to 2016 with revenues being USD ~ million in 2014. The hospitals market of the Philippines witnessed a growth when the government in November 2014, made it mandatory for all senior citizens to receive Phil Health insurance

This gave more ease to the people who were not financially well-off to undergo expensive surgeries and treatments. Number of patients visiting the hospitals increased with these health insurance benefits where they spent relatively less money on healthcare services, thereby generating revenues for the hospitals. Major private players operating in the market also served as the platform for medical tourism in the country.

The aging population which witnessed a rise in number of people from  ~ million in 2014 to ~ million in 2016 raised the demand for hospitals in the Philippines. With the growth of healthcare sector in the country, new hospitals were established so as to cater the rising demand of the population.

Which Revenue Streams Has Been Observed To Generate Highest Revenue For Hospitals In The Philippines?

Outpatient services dominated the hospitals market with revenue share of ~% in 2016 owing to the increased number of outpatient visits for medical consultations and check-ups by the qualified physicians and surgeons available the hospitals. The numbers of outpatient for almost all hospitals were more than twice the number of inpatients. For instance, Dr Jose N Rodriguez Memorial Hospital witnessed ~ outpatients in 2016, compared to ~ inpatients during the same year.

Services offered by diagnostic laboratories set up in the hospitals are also a considerable source of revenue for the market players. Majorly catering to the diagnostic needs of inpatients with technologically advanced procedures at prices prescribed by the hospitals, this segment adds ~% revenue to the overall revenues generated by the hospitals. Hospital-based pharmacies provide fixed amount or percentage of the revenue to the hospitals as per the conditions of the agreement. The revenue generated from hospital based pharmacies is increasing at a high rate as the patients also purchase

government, business entities, private organizations, PDAF, PSCO and other sources which cater to the funding needs of the hospitals for providing quality healthcare services to the patients in the Philippines. The PCSO donates to hospitals of the Philippines by providing financial assistance for the purchase of medical and surgical supplies, medical equipments and the construction and renovation of devolved and retained hospitals, municipal health centers, day care centers and also to private institutions implementing welfare programs nationwide.

The government of the Philippines has taken steps to increase the penetration of health insurance in the country. The government has made  health insurance scheme of Philippine Health Insurance Corp., PhilHealth mandatory for the population above 60 years of age. National Health Insurance Program (NHIP) administers the medical insurance in the entire country and has made mandatory to provide health insurance to the entire population either under PhilHealth or Private health insurance schemes. PhilHealth further covers the working class of the country wherein both employer and the employee contribute a minimal amount as premium for health insurance benefits of the employees. All these benefits ease the medical expenditure for the people of the Philippines.

The country has also witnessed private players entering the health insurance market and insuring people against healthcare expenditures Aging Population in the Philippines, Prevalence of Diabetes and Obesity in the Philippines, Upcoming Hospitals in the Philippines, Analysis of Major Private Hospitals In the Philippines, Culion Sanitarium and General Hospital Philippines, Veterans Memorial Medical Center Philippines, Philippine Heart Center, High Dependence on Government Hospitals Philippines, Rizal Medical Center Philippines,

Philippines Hospital trends The growing state of medical insurance has been responsible behind more people opting for hospital services even by private players apart from taking up the inexpensive medical services offered by the government hospitals in the Philippines.

The price competitive medical tourism market of the Philippines has witnessed more healthcare services being provided to people in the recent past. Lack of infrastructure made the market underdeveloped which is now positively changing due to skilled physicians, accredited hospitals, english speaking nurses and relatively inexpensive medical facilities of the country which makes it a global hub for medical tourism. Philippines were ranked eighth among the world’s top medical tourism destinations in 2015 and cater to ~ to ~ foreign patients annually.

In order to promote medical tourism of the Philippines, the Department of Health of the government along with Department of Tourism of the Philippines initiated Philippine Medical Tourism Program in 2006 so as to attract foreign patients to the medical services of the country. Government even collaborated with various private medical institutions for the purpose of quality healthcare and safety of international patients. Increasing medical tourism market will consequently impact the hospitals market in a positive manner leading to more number of services being provided to international patients.

Topics Covered in The Report

  • Southern Philippines Medical Center
  • Philippine Orthopedic Center
  • Lung Center of the Philippines
  • Vicente Sotto Memorial Medical Center
  • Healthcare Expenditure in the Philippines
  • Medical Tourism Industry of the Philippines
  • Aging Population in the Philippines
  • Prevalence of Diabetes and Obesity in the Philippines
  • Upcoming Hospitals in the Philippines
  • Culion Sanitarium and General Hospital Philippines
  • Veterans Memorial Medical Center Philippines
  • Philippine Heart Center
  • High Dependence on Government Hospitals Philippines
  • Rizal Medical Center Philippines
  • Philippines Hospital trends
  • Health Profile of the Philippines
  • Diagnostic Laboratories market Philippines
  • Hospital Based Pharmacies Philippines
  • Philippines Hospitals Statistics

MoreDetailsVisit : https://www.kenresearch.com/healthcare/general-healthcare/philippines-hospitals-market-report/105284-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

 

https://www.kenresearch.com/blog/2017/05/philippines-hospitals-market-size-basis-revenue-usd-million-ken-research/

Qatar Medical Devices Market Segmentation by Type of Application and Rationale for Revenue- ken Research


Qatar is an import driven market in context to medical devices. The imports of medical devices accounted for a lion share of ~% from the total revenue market in 2016. The market is observed to grow at a rapid pace of ~% by value from 2011 to 2016 owing to the expanding healthcare infrastructure in the country; both the government and private healthcare sector has been investing heavily to provide the country with satisfactory healthcare solutions to the residents and expats. Doha Clinic Hospital, Diabetic Population of Qatar, Per Capita Healthcare Spending in Qatar, Biomeriux Sales Qatar, Trends Qatar Drugs market, Doha Medicine Sales, Qatar Medical Devices Market Size, Market Sizing Hospitals Market.

Diagnostic imaging products were observed to capture the major share of the market (~% in 2016), however Scintigraphic apparatus and Magnetic resonance imaging apparatus recorded the highest growth in span 2016. In terms of demand for the products, household demand recorded exponential growth in the recent years by expanding at a CAGR of ~%, by value from 2011 to 2016.

 

High demand for technologically advanced equipment with rapidly developing healthcare infrastructure in the country led to high revenue generation from institutions. Institutional demand for medical devices in the Qatar dominated the Qatar healthcare market with revenue share of ~% in 2011 and ~% in 2016. Increased government healthcare spending to purchase innovative and expensive medical devices coupled with rising number of medical surgeries conducted in the country has helped the segment in gaining dominance in market, in terms of revenue in Qatar.

Household demand for medical devices experienced growth at a CAGR of ~% during the period 2011-2016. Technological advancements have allowed several medical devices which are especially used for regular monitoring of certain diseases to be used remotely from home and eliminating the need of frequent clinic visits. Increased sales of medical devices for dialysis, diabetes management and measuring blood pressure resulted in the incline in revenues from this segment. As of December 2016, out of the 1,000 patients with kidney disease, nearly 170 of them were on peritoneal dialysis.

What Is The Potential Of Qatar Healthcare Market?

Qatar healthcare market is one of the fastest growing markets in the world with the growth rate of ~% during the period 2011-2016. People across Qatar are facing several health care issues due to sedentary lifestyle and fast food consumption habits, such as obesity, diabetes, and other cardiovascular diseases, which are demanding for technologically advanced healthcare infrastructure. Qatar has been exponentially expanding its national healthcare system to cater the needs of its people and support economic diversification. The country has been developing its infrastructure including hospitals, diagnostic labs, and clinics in addition to the development of local clinicians, physicians and specialized doctors. In addition to all these factors, fast rising and ageing population in the country has also propelled the government to upgrade its public healthcare.

Medical hospitals in the country contributed to the maximum share of overall healthcare market as of 2016. Over ~% of the market revenues were generated from the hospitals segment.

Rising per capital expenditure on healthcare from USD ~ million in 2011 to USD ~ million in 2016 coupled with rising population from ~ million in 2011 to ~ million in 2016 has aided in the growth of the healthcare sector in the country.

Qatar healthcare market inclined at a CAGR of ~% during the period 2011-2016 from USD ~ million in 2011 to USD ~ million in 2016, primarily due to rising prevalence of non-communicable and lifestyle diseases including diabetes, asthma and heart disorders.

What Factors Have Led To High Import Of Medical Devices In Qatar?

Qatar is an import driven market in context to medical devices. The imports of medical devices accounted for a lion share of ~% from the total revenue market in 2016. The market is observed to grow at a rapid pace of ~% by value from 2011 to 2016 owing to the expanding healthcare infrastructure in the country; both the government and private healthcare sector has been investing heavily to provide the country with satisfactory healthcare solutions to the residents and expats. . Doha Clinic Hospital, Diabetic Population of Qatar, Per Capita Healthcare Spending in Qatar, Biomeriux Sales Qatar, Trends Qatar Drugs market, Doha Medicine Sales, Qatar Medical Devices Market Size, Market Sizing Hospitals Market.

Diagnostic imaging products were observed to capture the major share of the market (~% in 2016), however Scintigraphic apparatus and Magnetic resonance imaging apparatus recorded the highest growth in span 2016. In terms of demand for the products, household demand recorded exponential growth in the recent years by expanding at a CAGR of ~%, by value from 2011 to 2016.

Topics Covered in the Report

  • Doha Clinic Hospital
  • Diabetic Population of Qatar
  • Per Capita Healthcare Spending in Qatar
  • Biomeriux Sales Qatar
  • Teleradiology in Qatar
  • Trends Qatar Drugs
  • Doha Medicine Sales
  • Government Expenditure on Healthcare in Qata
  • Qatar Pharmaceuticals Market Size
  • Qatar Healthcare Market Size
  • Qatar Medical Devices Market Size
  • Market Sizing – Hospitals Market
  • Qatar Clinic and Health Center Market
  • Qatar Retail Pharmacy Market Segmentation

 

To know more on research report

https://www.kenresearch.com/healthcare/general-healthcare/qatar-healthcare-market-report/99730-91.html

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
Ankur@kenresearch.com
+91-9015378249

https://www.kenresearch.com/blog/2017/05/per-capita-healthcare-spending-in-qatar/

Strong hold of Limited Players in New Zealand Adult Oral Care Sector- Ken Research


In New Zealand there is a limited supply of adult mouth care product brands such as Reckitt Benckiser New Zealand’s Bonjela Oral Gel, iNova Pharmaceutical’s Difflam Mouth Gel and Hamilton Pharmaceutical’s Ora-Sed Gel. These brands are unavailable in pharmacies and grocery stores but are available in some online retail stores. Thus, these three brands are ruling the present New Zealand’s oral care market. Bonjela oral gel is classified as a general sale product; therefore it is readily available in any of the super markets across the country. The Difflam brand offers many oral relief products for cough and throat remedies, therefore has good business.

According to Ken Research Report “Adult Mouth Care in New Zealand”, New Zealand’s adult mouth care remains an important sector, predominantly for the country’s ageing population with symptoms of dry mouth. All the youngsters in New Zealand enjoy state-funded dental care until their eighteenth birthday. It was observed that after the eighteenth birthday youngsters were not funded for oral health that led them to decline their oral health.

According to the study conducted by Ken Research, cost is a barrier for adults because dental care is unaffordable for some communities. Research also reveals that a sensible diet and brushing teeth can give long term dental health benefits. Government funding on oral care has more than doubled the (GDP) Gross Domestic Product. The non-demographic factors play a major role in terms of health segment than the demographic factor.

The overall growth in 2016 was stronger due to the country’s floating economy and hike in prices. The public prospect of the health system increased as technology developed with various oral care treatment options that are affordable.

Every year in New Zealand, a day is set aside to provide free dental care to all the citizens of the country and the day is called as a Lumino Day. This year Lumino Day was held on May 7th 2017. On this day, more than 150 dentists gave free dental treatment worth $150,000 to 400 families in New Zealand.

New Zealand government in 1938 established Health Act where oral health care was actually a part of public health but it was not affordable at that time. The government on the other hand has taken measures to promote oral health care in adults from an early age.

Subsidised dental care was a traditional measure by the government of New Zealand; therefore, a new dental care policy would soon be released.

Topics covered in the Report

  • Adult mouth care industry New Zealand
  • New Zealand oral care industry research
  • New Zealand oral care market size
  • Dental care market New Zealand
  • New Zealand toothbrush market analysis
  • New Zealand oral care market trends
  • New Zealand oral care market future outlook
  • New Zealand oral care major players
  • Forecast Sales of Adult Mouth Care New Zealand
  • LBN Brand Shares of Adult Mouth Care New Zealand
  • NBO Company Shares of Adult Mouth Care New Zealand
  • Sales of Adult Mouth Care Value New Zealand
  • New Zealand Adult mouth care market growth
  • New Zealand Adult mouth care market Trends
  • New Zealand Adult mouth care market size
  • New Zealand Adult mouth care market share
  • New Zealand Adult mouth care market analysis
  • New Zealand Adult mouth care market future

To know more on publication, click here:

https://www.kenresearch.com/healthcare/pharmaceuticals/adult-mouth-care-new-zealand/100726-91.html

Related reports
Hospitals, Medical and Dental Services in Indonesia: ISIC 851

2017-2022 Global Top Countries Interdental Brush Market Report

Contact:

Ken Research

Ankur Gupta,

Head Marketing & Communications

query@kenresearch.com

+91-124- 4230204

www.kenresearch.com

https://www.kenresearch.com/blog/2017/05/strong-hold-limited-players-new-zealand-adult-oral-care-sector-ken-research/